1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6CF6182371916C05585257AB0006E0B7F
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/otc-medical-affairs-managing-retailers-pharmacists-point-of-care-communications-and-pharmacovigilance?opendocument
18
19opendocument
2044.222.134.250
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Business Operations » Organizational Strategy and Structure

OTC Medical Affairs Excellence: Managing Retailers, Pharmacists, Point of Care Communications & Pharmacovigilance in a Changing Biopharmaceutical Landscape

ID: 5230


Features:

23 Info Graphics

2 Data Graphics

20 Metrics

3 Narratives

7 Best Practices


Pages/Slides: 31


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "OTC Medical Affairs Excellence: Managing Retailers, Pharmacists, Point of Care Communications & Pharmacovigilance in a Changing Biopharmaceutical Landscape"

STUDY OVERVIEW

As the baby boomer population ages, demands for self-medication options will grow. There is a wide spectrum of drivers for this growth: cost shifting from governments and insurance carriers to consumers, increased consumer access to medical information and interest in managing their health, and greater industry awareness of lifecycle management for “old” drugs that are past patent protection but still play a therapeutic role. Underlying these factors is the recognition that a switch from prescription (Rx) to over-the-counter (OTC) status benefits public health by increasing consumer access to, and utilization of, effective therapies.

Using previous primary research and previous learning, Best Practices, LLC created this study to help the
Medical Affairs groups focus on areas that support best-in-class clinical science, patient safety, positive health outcomes, and success for the company. While many practices are focused on Rx Medical Affairs, this study offers insights into how these can be implemented into an OTC group.

KEY TOPICS
  • Executive Summary
  • Managing Retailers
  • Pharmacist Interaction
  • Point of Care Communications
  • Pharmacovigilance
  • Informing Stakeholders Through Scientific Publications & Education

SAMPLE KEY FINDING
  • Broader Spectrum of Customers/KOLs: While Rx bemoans its lack of access to physicians (main “customers”), OTC has a variety of customer segments it must reach -- retailers, pharmacists, advocacy groups and patients. Each group has specific touch points and tactics to ensure that proper attention has been provided.
  • The "Walmart" Era: Selling through large retailers presents a new challenges for pharma companies with OTC intentions. Consumers may not engage pharmacists or others for guidance, so Medical Information can be critical from the company.

METHODOLOGY

Insights were drawn from mining of previous research and extensive secondary research.


Industries Profiled:
Market Research; Manufacturing; Medical Device; Pharmaceutical; Financial Services; Service; Retail; Research; Computer Software; Diagnostic; Health Care; Transportation; Biotech; Clinical Research; Consulting; Distribution; Insurance; Hospitality; Telecommunications; Technology; Professional Services; High Tech; Automobile; Utilities; Energy; Consumer Products; Chemical; Medical; Electronics; Laboratories; Biopharmaceutical; Banking; Computers; Entertainment; Internet; Computer Hardware; Aerospace; Academic; Media; Education; Newspapers; Government; Shipping; Science; Office Supplies; Marketing; Office Equipment; Cable; Advertising; Defense; Military; Diversified; Sports; Technology; Public Relations; Multiple; Communications; Logistics; Publishing; Real Estate; Construction; Architecture; Engineering; Aviation; Legal; Test Industry; Non-Profit; Business; Orthopaedics


Companies Profiled:

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.